Patent · US Active

Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof

US11879002B2 · kind B2 · utility

0Cited by

24References

19Claims

0Family size

Assignee

Silver Creek Pharmaceuticals, Inc. · US

Inventors

Laura D.J. Antipov · Oakland, US
Shawdee Eshghi · Oakland, US
Kristopher M. Kuchenbecker · San Francisco, US
Bjorn L. Millard · Orinda, US
Matthew Onsum · Corona, US
Andrea D. Nickerson · San Francisco, US
Timothy R. Stowe · San Francisco, US
Yan Zhang · San Francisco, US

Key dates

Filing date	Sep 28, 2021
Grant date	Jan 23, 2024
Priority date	—
Expiry date	Mar 16, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/75
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.